Figures computed from official regulatory filings — .
Analysttarget 39 USD (+109%) · consensus 4.67/5 · 8 buy · 1 hold · 0 sell
Ownershipinsiders 9.26% · institutions 86.85% · short 15.7% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Vor Biopharma Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
7 buys94 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, LLCtrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) |
| RA CAPITAL MANAGEMENT, LLCtrack record | Exercise | $6.4K | SEC |
| RA CAPITAL MANAGEMENT, LLCtrack record | Exercise | $5.6K | SEC |
| RA CAPITAL MANAGEMENT, LLCtrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| RA CAPITAL MANAGEMENT, LLCtrack record | Sell | $4.2K | SEC |
| RA CAPITAL MANAGEMENT, LLCtrack record | OtherD (derivative) | $10.5M | SEC |
| RA CAPITAL MANAGEMENT, LLCtrack record | Other | $4.2K | SEC |
| ZACCARDELLI DAVID | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Joustra Wouter | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Namouni Fouad | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Beckman Daniella | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Kalir Erez | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| RA CAPITAL MANAGEMENT, LLCtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Cumbo Alexander | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Levin Andrew David | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Detheux Michel | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| RA CAPITAL MANAGEMENT, LLCtrack record | Sell | $2.6M | SEC |
| RA CAPITAL MANAGEMENT, LLCtrack record | Sell | $2.7M | SEC |
| RA CAPITAL MANAGEMENT, LLCtrack record | Sell | $7.5M | SEC |
| RA CAPITAL MANAGEMENT, LLCtrack record | Sell | $858.8K | SEC |
| RA CAPITAL MANAGEMENT, LLCtrack record | Sell | $2.5M | SEC |
| RA CAPITAL MANAGEMENT, LLCtrack record | Sell | $8.6M | Unusual size | SEC |
| RA CAPITAL MANAGEMENT, LLCtrack record | Sell | $13K | SEC |
| RA CAPITAL MANAGEMENT, LLCtrack record | Sell | $2.2M | SEC |
| RA CAPITAL MANAGEMENT, LLCtrack record | Sell | $5.8M | Unusual size | SEC |